Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.
[This corrects the article DOI: 10.1371/journal.pone.0034805.].
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0248926 |
_version_ | 1819032196634116096 |
---|---|
author | Anna Bobrowska Gizem Donmez Andreas Weiss Leonard Guarente Gillian Bates |
author_facet | Anna Bobrowska Gizem Donmez Andreas Weiss Leonard Guarente Gillian Bates |
author_sort | Anna Bobrowska |
collection | DOAJ |
description | [This corrects the article DOI: 10.1371/journal.pone.0034805.]. |
first_indexed | 2024-12-21T06:58:06Z |
format | Article |
id | doaj.art-45ad3dad1c9e4a9d8a306d128b8e5948 |
institution | Directory Open Access Journal |
issn | 1932-6203 |
language | English |
last_indexed | 2024-12-21T06:58:06Z |
publishDate | 2021-01-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS ONE |
spelling | doaj.art-45ad3dad1c9e4a9d8a306d128b8e59482022-12-21T19:12:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01163e024892610.1371/journal.pone.0248926Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo.Anna BobrowskaGizem DonmezAndreas WeissLeonard GuarenteGillian Bates[This corrects the article DOI: 10.1371/journal.pone.0034805.].https://doi.org/10.1371/journal.pone.0248926 |
spellingShingle | Anna Bobrowska Gizem Donmez Andreas Weiss Leonard Guarente Gillian Bates Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo. PLoS ONE |
title | Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo. |
title_full | Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo. |
title_fullStr | Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo. |
title_full_unstemmed | Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo. |
title_short | Correction: SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo. |
title_sort | correction sirt2 ablation has no effect on tubulin acetylation in brain cholesterol biosynthesis or the progression of huntington s disease phenotypes in vivo |
url | https://doi.org/10.1371/journal.pone.0248926 |
work_keys_str_mv | AT annabobrowska correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT gizemdonmez correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT andreasweiss correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT leonardguarente correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo AT gillianbates correctionsirt2ablationhasnoeffectontubulinacetylationinbraincholesterolbiosynthesisortheprogressionofhuntingtonsdiseasephenotypesinvivo |